Home › Prediabetes › Virginia › Richmond
Prediabetes clinical trials in Richmond, VA
4 studies for Prediabetes are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
- Clinical Research Partners, LLC, Richmond
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
RecruitingHealthy volunteers welcome
- Chippenham Johnston Willis Medical Center, Richmond
Integrating a Prescription Produce Program Within a Diabetes Prevention Program
Recruiting
- Virginia Commonwealth University, Richmond
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
RecruitingPhase 4
- Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond
About Prediabetes
Prediabetes happens when your blood sugar levels are higher than normal but not high enough to be called diabetes.
More about Prediabetes on MedlinePlus
Prediabetes trials in other cities
- Atlanta, GA6 studies
- Boston, MA5 studies
- New York City, NY5 studies
- Los Angeles, CA5 studies
- Lexington, KY4 studies
- Mountain View, CA4 studies
- Houston, TX4 studies
- Little Rock, AR3 studies
- Nashville, TN3 studies
- San Diego, CA3 studies
- Minneapolis, MN3 studies
- Honolulu, HI3 studies
Other studies in Richmond
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Prostate Cancer19 studies
- Heart Failure17 studies
- Lung Cancer15 studies
- Cardiovascular Disease13 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Colorectal Cancer13 studies
- Cancer (all types)12 studies
- Metastatic Cancer12 studies
- Diffuse Large B-Cell Lymphoma11 studies
- Steatotic Liver Disease11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.